Kazuo Momma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kazuo Momma has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Toshio Nakanishi
Tokyo Women’s Medical University
6 shared publicationsKatsuaki Toyoshima
Tokyo Women’s Medical University
5 shared publicationsEmiko Hayama
Tokyo Women’s Medical University
2 shared publicationsFang Sun
2 shared publicationsShinichiro Imamura
2 shared publicationsAkira Ishizawa
Division of Cardiology, National Children's Hospital
1 shared publication
Latest Publications
- Open Access
- 29 February 2020
- Published by Springer Nature
- p. 251-257
Constriction of the Ductus Arteriosus with KATP Channel Inhibitors
The cause of fetal death by sulfonylureas (SUs), used for diabetes in pregnancy in the early 1960s, remained unsolved for decades. In 1993, Nakanishi discovered constriction of ductus arteriosus (DA) strips in rabbit fetuses with glibenclamide, a SU and inhibitor of the KATP channel. Later, Momma showed dose-dependent fetal DA constriction by glibenclamide injected directly into the fetus in rats. Every first-generation SU constricted the fetal DA by oral administration to the pregnant rat. DA constriction with the clinical dose of these SUs was mild, whereas a 100 times larger dose was needed to close the DA completely. Coadministration of SUs and cylooxygenase inhibitors caused additive severe constriction and complete closure of the fetal DA. These data suggested that the aforementioned high fetal death rate (63% in 1962) with chlorpropamide was due to the coadministration of this SU and aspirin-like drugs.
- 29 February 2020
- Published by Springer Nature
- p. 251-257
Open AccessConstriction of the Ductus Arteriosus with KATP Channel Inhibitors
The cause of fetal death by sulfonylureas (SUs), used for diabetes in pregnancy in the early 1960s, remained unsolved for decades. In 1993, Nakanishi discovered constriction of ductus arteriosus (DA) strips in rabbit fetuses with glibenclamide, a SU and inhibitor of the KATP channel. Later, Momma showed dose-dependent fetal DA constriction by glibenclamide injected directly into the fetus in rats. Every first-generation SU constricted the fetal DA by oral administration to the pregnant rat. DA constriction with the clinical dose of these SUs was mild, whereas a 100 times larger dose was needed to close the DA completely. Coadministration of SUs and cylooxygenase inhibitors caused additive severe constriction and complete closure of the fetal DA. These data suggested that the aforementioned high fetal death rate (63% in 1962) with chlorpropamide was due to the coadministration of this SU and aspirin-like drugs.
- Open Access
- 1 September 2019
- Published by The Japanese Society of Pediatric Cardiology and Cardiac Surgery in Pediatric Cardiology and Cardiac Surgery
- Vol. 35 (3) , 164-171
Tetralogy of Fallot with Absent Pulmonary Valve in the Rat: Fetal Heart and Lung Cross-Sectional Morphology
肺動脈弁欠損を伴うFallot四徴症(TF/APV)は肺動脈弁欠損症候群(APVS)とも呼ばれ,しばしば予後不良である.本症は周産期医療における胎児心エコー検査上重要な疾患である.Bis-diamineは強力なteratogenでラットに先天性心疾患と胸腺低形成を生じる.Bis-diamine 200 mgを妊娠9日と10日にラット40匹に胃内注入し,満期21日目に胎仔を全身急速凍結法,凍結ミクロトーム,実体顕微鏡(Wild M400)を用いて0.5 mm毎の胸部横断面を連続写眞で記録した.330胎仔に各種先天性心疾患(90%),胸腺低形成(100%)を生じた.肺動脈弁欠損を伴うFallot四徴症が46例にあり,その記録で次の所見が得られた.全例大きい心室中隔欠損があり,太い大動脈が心室中隔欠損に騎乗して起始していた.右室漏斗部はやや狭く,肺動脈弁は痕跡的または全く欠損し,動脈管は欠損していた.主肺動脈と左右肺動脈は拡大し,左右肺門部で最も大きく,気管と気管支を圧排して閉塞していた.これら肺動脈弁欠損を伴うFallot四徴症の生体内断面図を胎児エコーモデル図譜として提示する.
- 1 September 2019
- Published by The Japanese Society of Pediatric Cardiology and Cardiac Surgery in Pediatric Cardiology and Cardiac Surgery
- Vol. 35 (3) , 164-171
Open AccessTetralogy of Fallot with Absent Pulmonary Valve in the Rat: Fetal Heart and Lung Cross-Sectional Morphology
肺動脈弁欠損を伴うFallot四徴症(TF/APV)は肺動脈弁欠損症候群(APVS)とも呼ばれ,しばしば予後不良である.本症は周産期医療における胎児心エコー検査上重要な疾患である.Bis-diamineは強力なteratogenでラットに先天性心疾患と胸腺低形成を生じる.Bis-diamine 200 mgを妊娠9日と10日にラット40匹に胃内注入し,満期21日目に胎仔を全身急速凍結法,凍結ミクロトーム,実体顕微鏡(Wild M400)を用いて0.5 mm毎の胸部横断面を連続写眞で記録した.330胎仔に各種先天性心疾患(90%),胸腺低形成(100%)を生じた.肺動脈弁欠損を伴うFallot四徴症が46例にあり,その記録で次の所見が得られた.全例大きい心室中隔欠損があり,太い大動脈が心室中隔欠損に騎乗して起始していた.右室漏斗部はやや狭く,肺動脈弁は痕跡的または全く欠損し,動脈管は欠損していた.主肺動脈と左右肺動脈は拡大し,左右肺門部で最も大きく,気管と気管支を圧排して閉塞していた.これら肺動脈弁欠損を伴うFallot四徴症の生体内断面図を胎児エコーモデル図譜として提示する.
- Open Access
- 1 March 2018
- Published by The Japanese Society of Pediatric Cardiology and Cardiac Surgery in Pediatric Cardiology and Cardiac Surgery
- Vol. 34 (2) , 55-62
Cross-sectional Morphology of Congenital Heart Disease: Fetal Echocardiography Indicating Chromosome 22q11.2 Deletion Syndrome in Rat Model
総合学術電子ジャーナルサイト「J-STAGE」-国内で発行された学術論文全文を読むことのできる、日本最大級の総合電子ジャーナルプラットフォームです。
- 1 March 2018
- Published by The Japanese Society of Pediatric Cardiology and Cardiac Surgery in Pediatric Cardiology and Cardiac Surgery
- Vol. 34 (2) , 55-62
Open AccessCross-sectional Morphology of Congenital Heart Disease: Fetal Echocardiography Indicating Chromosome 22q11.2 Deletion Syndrome in Rat Model
総合学術電子ジャーナルサイト「J-STAGE」-国内で発行された学術論文全文を読むことのできる、日本最大級の総合電子ジャーナルプラットフォームです。
- Open Access
- 25 June 2016
- Published by Springer Nature
- p. 263-265
Fetal and Neonatal Ductus Arteriosus Is Regulated with ATP-Sensitive Potassium Channel
- 25 June 2016
- Published by Springer Nature
- p. 263-265
Open AccessFetal and Neonatal Ductus Arteriosus Is Regulated with ATP-Sensitive Potassium Channel
- 1 June 2010
- Published by Elsevier in The American Journal of Cardiology
- Vol. 105 (11) , 1617-1624
Cardiovascular Anomalies Associated With Chromosome 22q11.2 Deletion Syndrome
- 1 June 2010
- Published by Elsevier in The American Journal of Cardiology
- Vol. 105 (11) , 1617-1624
Cardiovascular Anomalies Associated With Chromosome 22q11.2 Deletion Syndrome
- 19 February 2009
- Published by S. Karger AG in Neonatology
- Vol. 96 (2) , 69-79
Delayed Neonatal Closure of the Ductus Arteriosus Following Early in utero Exposure to Indomethacin in the Rat
Background: Indomethacin is used to close the patent ductus arteriosus in premature infants and for tocolysis of preterm labor. Clinically and experimentally, early in utero exposure to indomethacin induces the paradoxical delay of postnatal closure of the ductus arteriosus. Objectives: To clarify the pharmacological nature of the delay of closure of the ductus arteriosus in the rat. Methods: We studied early in utero exposure to indomethacin (dose and timing) in addition to other drugs, inducing a delay in postnatal ductal closure. Pregnant rats at near term were studied by cesarean section on gestational day 21 (D21), incubated in room air at 33°C, followed by rapid whole-body freezing. Results: The delay in closure of the ductus arteriosus was dose dependent. A large dose of indomethacin (10 mg/kg) 1 or 2 days before birth induced a delay of 3–4 times. A timing study revealed maximum delay with administration of indomethacin 2 days before birth and minimum delay with administration 5 days before. Aspirin, ibuprofen, the selective COX1 inhibitor SC 560, the selective COX2 inhibitor rofecoxib and a prostaglandin EP4 receptor blocker, ONO-208, all delayed neonatal ductal closure following maternal administration on D19 and D20. Conclusions: The delay by indomethacin was dose dependent. The maximum delay was induced by 2 doses of 10 mg/kg indomethacin on D19 and D20. The delay was induced by a decreased stimulus to the prostaglandin EP4 receptor system in the last 2 days in utero. The delay was temporary with recovery 3 days or more after exposure.
- 19 February 2009
- Published by S. Karger AG in Neonatology
- Vol. 96 (2) , 69-79
Delayed Neonatal Closure of the Ductus Arteriosus Following Early in utero Exposure to Indomethacin in the Rat
Background: Indomethacin is used to close the patent ductus arteriosus in premature infants and for tocolysis of preterm labor. Clinically and experimentally, early in utero exposure to indomethacin induces the paradoxical delay of postnatal closure of the ductus arteriosus. Objectives: To clarify the pharmacological nature of the delay of closure of the ductus arteriosus in the rat. Methods: We studied early in utero exposure to indomethacin (dose and timing) in addition to other drugs, inducing a delay in postnatal ductal closure. Pregnant rats at near term were studied by cesarean section on gestational day 21 (D21), incubated in room air at 33°C, followed by rapid whole-body freezing. Results: The delay in closure of the ductus arteriosus was dose dependent. A large dose of indomethacin (10 mg/kg) 1 or 2 days before birth induced a delay of 3–4 times. A timing study revealed maximum delay with administration of indomethacin 2 days before birth and minimum delay with administration 5 days before. Aspirin, ibuprofen, the selective COX1 inhibitor SC 560, the selective COX2 inhibitor rofecoxib and a prostaglandin EP4 receptor blocker, ONO-208, all delayed neonatal ductal closure following maternal administration on D19 and D20. Conclusions: The delay by indomethacin was dose dependent. The maximum delay was induced by 2 doses of 10 mg/kg indomethacin on D19 and D20. The delay was induced by a decreased stimulus to the prostaglandin EP4 receptor system in the last 2 days in utero. The delay was temporary with recovery 3 days or more after exposure.
- 11 December 2008
- Published by S. Karger AG in Neonatology
- Vol. 95 (4) , 324-331
In vivo Dilatation of the Ductus Arteriosus by Rho Kinase Inhibition in the Rat
Background: Fasudil hydrochloride, a Rho kinase inhibitor, was reported to dilate the constricted ductus arteriosus in vitro, and was suggested as a neonatal bridge to heart surgery. Objectives: To clarify the in vivo effectiveness of fasudil to dilate the neonatal ductus arteriosus, and its usefulness as a bridge to heart surgery. Methods: We studied the dose and timing of administration of fasudil in the neonatal rat. Postnatal ductal closure was studied on the 21st gestational day following cesarean section and incubation for 30–480 min in room air at 33°C, with a rapid whole-body freezing method. In control rats, the ductus closed rapidly after birth, and the ductal diameter was 0.80 and 0.12 mm at 0 and 30 min after birth. Fasudil was injected peritoneally into the neonate, and the ductus was studied 30 min after injection and 60 min after birth. Results: Fasudil, 10 mg/kg, injected within 5 min after birth, dilated the ductus completely to 0.8 mm, and the dose used clinically, 1 mg/kg, dilated the ductus to 0.4 mm. The ductus-dilating effect of fasudil decreased rapidly as the neonatal ductus constricted. Fasudil, 100 mg/kg, dilated the ductus completely, but induced severe respiratory depression and frequent death in 1-hour-old rats. Conclusions: Fasudil dilates the neonatal ductus arteriosus dose-dependently in the rat. Fasudil in large doses dilates the neonatal ductus completely, but is associated with fatal side effects, including respiratory depression.
- 11 December 2008
- Published by S. Karger AG in Neonatology
- Vol. 95 (4) , 324-331
In vivo Dilatation of the Ductus Arteriosus by Rho Kinase Inhibition in the Rat
Background: Fasudil hydrochloride, a Rho kinase inhibitor, was reported to dilate the constricted ductus arteriosus in vitro, and was suggested as a neonatal bridge to heart surgery. Objectives: To clarify the in vivo effectiveness of fasudil to dilate the neonatal ductus arteriosus, and its usefulness as a bridge to heart surgery. Methods: We studied the dose and timing of administration of fasudil in the neonatal rat. Postnatal ductal closure was studied on the 21st gestational day following cesarean section and incubation for 30–480 min in room air at 33°C, with a rapid whole-body freezing method. In control rats, the ductus closed rapidly after birth, and the ductal diameter was 0.80 and 0.12 mm at 0 and 30 min after birth. Fasudil was injected peritoneally into the neonate, and the ductus was studied 30 min after injection and 60 min after birth. Results: Fasudil, 10 mg/kg, injected within 5 min after birth, dilated the ductus completely to 0.8 mm, and the dose used clinically, 1 mg/kg, dilated the ductus to 0.4 mm. The ductus-dilating effect of fasudil decreased rapidly as the neonatal ductus constricted. Fasudil, 100 mg/kg, dilated the ductus completely, but induced severe respiratory depression and frequent death in 1-hour-old rats. Conclusions: Fasudil dilates the neonatal ductus arteriosus dose-dependently in the rat. Fasudil in large doses dilates the neonatal ductus completely, but is associated with fatal side effects, including respiratory depression.
- 1 January 2006
- Published by Springer Nature in Pediatric Drugs
- Vol. 8 (1) , 55-69
ACE Inhibitors in Pediatric Patients with Heart Failure
This article reviews reports of ACE inhibitor use in pediatric heart failure and summarizes the present implications for clinical practice. Captopril, enalapril, and cilazapril are orally active ACE...
- 1 January 2006
- Published by Springer Nature in Pediatric Drugs
- Vol. 8 (1) , 55-69
ACE Inhibitors in Pediatric Patients with Heart Failure
This article reviews reports of ACE inhibitor use in pediatric heart failure and summarizes the present implications for clinical practice. Captopril, enalapril, and cilazapril are orally active ACE...
- 31 December 2005
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 78 (1-4) , 117-128
In vivo reopening of the neonatal ductus arteriosus by a prostanoid EP4-receptor agonist in the rat
- 31 December 2005
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 78 (1-4) , 117-128
In vivo reopening of the neonatal ductus arteriosus by a prostanoid EP4-receptor agonist in the rat